Back to DNLI

Denali Therapeutics Inc. 8-K

Accession 0001628280-22-026765

Filing information

CIK
0001714899
Report date
2022-10-19
Filing date
2022-10-20
Form
8-K
Primary document
dnli-20221019.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.